TY - JOUR
T1 - Systematic Development of Sandwich Immunoassays for the Plasma Secretome
AU - Häussler, Ragna S.
AU - Bendes, Annika
AU - Iglesias, Maria Jesus
AU - Sanchez-Rivera, Laura
AU - Dodig-Crnković, Tea
AU - Byström, Sanna
AU - Fredolini, Claudia
AU - Birgersson, Elin
AU - Dale, Matilda
AU - Edfors, Fredrik
AU - Fagerberg, Linn
AU - Rockberg, Johan
AU - Tegel, Hanna
AU - Uhlén, Mathias
AU - Qundos, Ulrika
AU - Schwenk, Jochen M.
PY - 2019
Y1 - 2019
N2 - The plasma proteome offers a clinically useful window into human health. Recent advances from highly multiplexed assays now call for appropriate pipelines to validate individual candidates. Here, a workflow is developed to build dual binder sandwich immunoassays (SIA) and for proteins predicted to be secreted into plasma. Utilizing suspension bead arrays, ≈1800 unique antibody pairs are first screened against 209 proteins with recombinant proteins as well as EDTA plasma. Employing 624 unique antibodies, dilution-dependent curves in plasma and concentration-dependent curves of full-length proteins for 102 (49%) of the targets are obtained. For 22 protein assays, the longitudinal, interindividual, and technical performance is determined in a set of plasma samples collected from 18 healthy subjects every third month over 1 year. Finally, 14 of these assays are compared with with SIAs composed of other binders, proximity extension assays, and affinity-free targeted mass spectrometry. The workflow provides a multiplexed approach to screen for SIA pairs that suggests using at least three antibodies per target. This design is applicable for a wider range of targets of the plasma proteome, and the assays can be applied for discovery but also to validate emerging candidates derived from other platforms.
AB - The plasma proteome offers a clinically useful window into human health. Recent advances from highly multiplexed assays now call for appropriate pipelines to validate individual candidates. Here, a workflow is developed to build dual binder sandwich immunoassays (SIA) and for proteins predicted to be secreted into plasma. Utilizing suspension bead arrays, ≈1800 unique antibody pairs are first screened against 209 proteins with recombinant proteins as well as EDTA plasma. Employing 624 unique antibodies, dilution-dependent curves in plasma and concentration-dependent curves of full-length proteins for 102 (49%) of the targets are obtained. For 22 protein assays, the longitudinal, interindividual, and technical performance is determined in a set of plasma samples collected from 18 healthy subjects every third month over 1 year. Finally, 14 of these assays are compared with with SIAs composed of other binders, proximity extension assays, and affinity-free targeted mass spectrometry. The workflow provides a multiplexed approach to screen for SIA pairs that suggests using at least three antibodies per target. This design is applicable for a wider range of targets of the plasma proteome, and the assays can be applied for discovery but also to validate emerging candidates derived from other platforms.
U2 - 10.1002/pmic.201900008
DO - 10.1002/pmic.201900008
M3 - Journal article
C2 - 31278833
SN - 1615-9853
VL - 19
JO - Proteomics
JF - Proteomics
IS - 15
M1 - 1900008
ER -